🇮🇳IN
Sign In
AS

ASTRAZEN

NSE

AstraZeneca Pharma India Limited

₹6,299.00

+62.00(+0.99%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

ASTRAZEN valuation summary

AstraZeneca Pharma India Limited trades at 84.1 times trailing earnings. Return on equity is 23.3% and return on capital employed is 29.3%. The dividend yield is 0.62%.

P/E84.1
ROE23.3%
ROCE29.3%
Dividend yield0.62%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer